| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 334.032.626 $ | 100,28 | 7.535.631 | |||||||
| Pfizer Inc. | Pfizer Inc. | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 17.365.520 $ | 5,21 | 650.394 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 16.479.555 $ | 4,95 | 71.697 | |
| AbbVie Inc. | AbbVie Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 16.328.062 $ | 4,90 | 77.267 | |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 15.962.471 $ | 4,79 | 46.101 | |
| Eli Lilly and Co. | Eli Lilly and Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 15.845.208 $ | 4,76 | 16.954 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 15.642.315 $ | 4,70 | 119.553 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 15.549.634 $ | 4,67 | 142.422 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 13.988.197 $ | 4,20 | 154.072 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 13.333.844 $ | 4,00 | 316.568 | |
| Corcept Therapeutics Inc. | Corcept Therapeutics Inc. | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 12.465.778 $ | 3,74 | 267.966 | |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 11.863.024 $ | 3,56 | 51.702 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 11.795.521 $ | 3,54 | 20.645 | |
| Liquidia Corp. | Liquidia Corp. | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 11.417.952 $ | 3,43 | 291.200 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 11.415.612 $ | 3,43 | 56.229 | |
| Harmony Biosciences Holdings, Inc. | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 10.840.280 $ | 3,25 | 346.778 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 10.229.145 $ | 3,07 | 1.091.691 | |
| ANI Pharmaceuticals, Inc. | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 10.125.585 $ | 3,04 | 127.446 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 9.616.057 $ | 2,89 | 158.707 | |
| Innoviva, Inc. | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 9.596.072 $ | 2,88 | 417.402 | |
| Biogen Inc. | Biogen Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 9.479.900 $ | 2,85 | 50.084 | |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 9.091.124 $ | 2,73 | 608.509 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 8.942.188 $ | 2,68 | 12.647 | |
| Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 8.803.248 $ | 2,64 | 183.401 | |
| Amneal Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 8.582.450 $ | 2,58 | 666.857 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 8.289.655 $ | 2,49 | 130.320 | |
| Prestige Consumer Healthcare Inc. | Prestige Consumer Healthcare Inc. | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 8.003.523 $ | 2,40 | 142.108 | |
| Perrigo Co. PLC | Perrigo Co. PLC | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 7.922.748 $ | 2,38 | 669.151 | |
| Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 7.758.753 $ | 2,33 | 353.313 | |
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 7.299.206 $ | 2,19 | 216.401 | |
| OmniAb, Inc. | OmniAb, Inc., Rts., expiring 2027-11-02 | EC | 68218J301 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 78.046 | |
| 334.032.626 $ | 100,28 | 7.535.631 |